Inspire Medical Systems, Inc. Revenues
Inspire Medical Systems, Inc. (INSP) reported Revenues of $26.91 million for the 3-month period ending 2019-12-31, per its 10-K filed 2020-02-25.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2020-02-25
- Inspire Medical Systems, Inc. revenues for the quarter ending 2019-12-31 was $26.91M, a 62.49% increase year-over-year.
- Inspire Medical Systems, Inc. revenues for the quarter ending 2019-09-30 was $20.86M, a 59.81% increase year-over-year.
- Inspire Medical Systems, Inc. revenues for the quarter ending 2019-06-30 was $18.03M, a 64.86% increase year-over-year.
- Inspire Medical Systems, Inc. revenues for the quarter ending 2019-03-31 was $16.25M, a 61.82% increase year-over-year.
- Inspire Medical Systems, Inc. revenues for fiscal 2019 was $82.05M, a 62.18% increase from fiscal 2018.
- Inspire Medical Systems, Inc. revenues for fiscal 2018 was $50.59M, a 77.10% increase from fiscal 2017.
- Inspire Medical Systems, Inc. revenues for fiscal 2017 was $28.57M, a 73.90% increase from fiscal 2016.
- Inspire Medical Systems, Inc. revenues for fiscal 2016 was $16.43M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2019-12-31 | $26.91M 10-K · filed 2020-02-25 | $47.77M derived: sum of 2 quarters · filed 2020-02-25 | $65.80M derived: sum of 3 quarters · filed 2020-02-25 | $82.05M 10-K · filed 2020-02-25 |
| 2019-09-30 | $20.86M 10-K · filed 2020-02-25 | $38.89M derived: sum of 2 quarters · filed 2020-02-25 | $55.14M derived: sum of 3 quarters · filed 2020-02-25 | $71.70M derived: sum of 4 quarters · filed 2020-02-25 |
| 2019-06-30 | $18.03M 10-K · filed 2020-02-25 | $34.28M derived: sum of 2 quarters · filed 2020-02-25 | $50.84M derived: sum of 3 quarters · filed 2020-02-25 | $63.90M derived: sum of 4 quarters · filed 2020-02-25 |
| 2019-03-31 | $16.25M 10-K · filed 2020-02-25 | $32.81M derived: sum of 2 quarters · filed 2020-02-25 | $45.86M derived: sum of 3 quarters · filed 2020-02-25 | $56.80M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-12-31 | $16.56M 10-K · filed 2020-02-25 | $29.61M derived: sum of 2 quarters · filed 2020-02-25 | $40.55M derived: sum of 3 quarters · filed 2020-02-25 | $50.59M 10-K · filed 2020-02-25 |
| 2018-09-30 | $13.05M 10-K · filed 2020-02-25 | $23.99M derived: sum of 2 quarters · filed 2020-02-25 | $34.03M 10-Q · filed 2018-11-06 | $43.99M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $10.94M 10-K · filed 2020-02-25 | $20.98M 10-Q · filed 2018-08-07 | $30.94M derived: sum of 3 quarters · filed 2020-02-25 | $38.21M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $10.04M 10-K · filed 2020-02-25 | $20.00M derived: sum of 2 quarters · filed 2020-02-25 | $27.27M derived: sum of 3 quarters · filed 2020-02-25 | $33.31M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $9.96M 10-K · filed 2019-02-26 | $17.23M derived: sum of 2 quarters · filed 2019-02-26 | $23.27M derived: sum of 3 quarters · filed 2019-02-26 | $28.57M 10-K · filed 2020-02-25 |
| 2017-09-30 | $7.27M 10-K · filed 2019-02-26 | $13.31M derived: sum of 2 quarters · filed 2019-02-26 | $18.61M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $6.04M 10-K · filed 2019-02-26 | $11.34M 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $5.30M 10-K · filed 2019-02-26 | |||
| 2016-12-31 | $16.43M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |